Cochrane Abstracts
Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Pegylated Liposomal Doxorubicin for Relapsed Epithelial Ovarian Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434320/all/Pegylated_liposomal_doxorubicin_for_relapsed_epithelial_ovarian_cancer. Accessed 14 October 2024.
Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434320/all/Pegylated_liposomal_doxorubicin_for_relapsed_epithelial_ovarian_cancer. Accessed October 14, 2024.
Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434320/all/Pegylated_liposomal_doxorubicin_for_relapsed_epithelial_ovarian_cancer
Pegylated Liposomal Doxorubicin for Relapsed Epithelial Ovarian Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 October 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434320/all/Pegylated_liposomal_doxorubicin_for_relapsed_epithelial_ovarian_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer
ID - 434320
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434320/all/Pegylated_liposomal_doxorubicin_for_relapsed_epithelial_ovarian_cancer
DB - Evidence Central
DP - Unbound Medicine
ER -
